Literature DB >> 16640496

Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes.

Makiya Nishikawa1, Mitsuru Hashida.   

Abstract

Metastasis is one of the most harmful aspects of malignant neoplasm. Interaction of tumour cells with normal cells such as tissue macrophages may generate reactive oxygen species, which would affect various aspects of tumour metastasis. Reactive oxygen species cause damage to both tumour and normal cells and some of them, especially hydrogen peroxide, can also act as intracellular second messengers at sublethal concentrations to increase the transcription of various genes, which can then accelerate the proliferation of tumour cells in metastatic colonies. Therefore, eliminating hydrogen peroxide is one approach to inhibiting tumour metastasis. In this article, the roles of reactive oxygen species in tumour metastasis are reviewed, and the strategies to inhibit tumour metastasis by the targeted delivery of catalase, an enzyme that detoxifies hydrogen peroxide, are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16640496     DOI: 10.1517/17425247.3.3.355

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  13 in total

Review 1.  Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis.

Authors:  Stephanos Pavlides; Iset Vera; Ricardo Gandara; Sharon Sneddon; Richard G Pestell; Isabelle Mercier; Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Antioxid Redox Signal       Date:  2011-11-17       Impact factor: 8.401

2.  Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer".

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Zhao Lin; Stephanos Pavlides; Diana Whitaker-Menezes; Richard G Pestell; Anthony Howell; Federica Sotgia
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

3.  Accelerated aging in the tumor microenvironment: connecting aging, inflammation and cancer metabolism with personalized medicine.

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Diana Whitaker-Menezes; Richard G Pestell; Anthony Howell; Federica Sotgia
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

4.  Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines.

Authors:  Rajaa Hussien; George A Brooks
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

5.  Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors.

Authors:  Ubaldo E Martinez-Outschoorn; Zhao Lin; Casey Trimmer; Neal Flomenberg; Chenguang Wang; Stephanos Pavlides; Richard G Pestell; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

6.  SOD derivatives prevent metastatic tumor growth aggravated by tumor removal.

Authors:  Kenji Hyoudou; Makiya Nishikawa; Yuki Kobayashi; Mai Ikemura; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Clin Exp Metastasis       Date:  2008-03-21       Impact factor: 5.150

7.  Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice.

Authors:  Ramune Reliene; Sheila M Fleming; Marie-Françoise Chesselet; Robert H Schiestl
Journal:  Food Chem Toxicol       Date:  2007-08-29       Impact factor: 6.023

8.  Mitochondrial targeted catalase suppresses invasive breast cancer in mice.

Authors:  Jorming Goh; Linda Enns; Soroosh Fatemie; Heather Hopkins; John Morton; Christina Pettan-Brewer; Warren Ladiges
Journal:  BMC Cancer       Date:  2011-05-23       Impact factor: 4.430

9.  Experimental antioxidant therapy in ataxia telangiectasia.

Authors:  Ramune Reliene; Robert H Schiestl
Journal:  Clin Med Oncol       Date:  2008-05-20

10.  Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo.

Authors:  Hidemasa Katsumi; Jun-Ichi Sano; Makiya Nishikawa; Keiko Hanzawa; Toshiyasu Sakane; Akira Yamamoto
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.